XML 27 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accounts Receivable
 12 Months Ended
Dec. 31, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]  
Accounts Receivable Accounts Receivable
Accounts receivable consisted of the following as of December 31, 2024 and 2023:
 December 31,
2024		December 31,
2023
Government receivables$26,338 $35,529 
Pharmacy rebate receivables111,813 75,894 
Other receivables15,753 8,326 
Total accounts receivable153,904 119,749 
Allowance for credit losses— — 
Accounts receivable, net$153,904 $119,749 
The allowance for expected credit losses for accounts receivable is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. We record pharmacy rebates and other receivables based on contractual terms and expected collections and our estimation process for contractual allowances for such balances generally results in an allowance for balances outstanding greater than 90 days or if expected credit risks are known.
Receivables and any associated allowance are written off only when all collection attempts have failed and such amounts are determined unrecoverable. We regularly review the adequacy of these allowances based on a variety of factors, including age of the outstanding receivable and collection history. When circumstances related to specific collection patterns change, estimates of the recoverability of receivables are adjusted. Because substantially all of our receivable amounts are readily determinable and a large portion of our creditors are governmental authorities, our allowance for credit losses is insignificant.
We recorded credit losses related to accounts receivable of $123, $91, and $150 during the years ended December 31, 2024, 2023, and 2022, respectively. The amounts were recorded in selling general, and administrative expenses in the consolidated statements of operations.